Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
The investment case for Eaton EFR in simple terms 009 20260511 BauschHealth BHC Stock Momentum Outlook Q4 2025 Profit Disappoints IHT InnSuites posts 15 percent year over year revenue growth in Q1 2026 shares edge higher US Commercial Aviation Proposed MegaMerger Analysis CHR Cheer reports 11 percent Q1 2026 revenue growth shares dip 117 percent after quarterly earnings release AI Hallucinations Are Infiltrating Expert Work Raising Concerns for Knowledge Integrity and Professional Liability AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests Sebi Bars Seven Entities for Stock Manipulation via Social Media Freezes 20 Crore Gains Analysts Reassess Pinterest Incs Growth Prospects Amid Digital Advertising Shift Zscaler Stock Plunges Over 30 After Disappointing Revenue Outlook South Koreas Deputy PM Warns AI Wealth May Not Reach the Public as Samsung Labor Disputes Simmer BTMD Q1 2026 Earnings EPS Beats Estimates Stock Rises 26 Evolus EOLS Q1 2026 Earnings EPS Surprises Positively Despite Stock Decline AGM Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher PMTV Q1 2026 Earnings EPS Misses Estimates by 58 Stock Edges Higher BKNG Q1 2026 Earnings EPS Beats Expectations Amid Travel Demand Strength Autoliv Inc ALV Surges 2 Key Levels to Watch as Safety Supplier Holds Above Support Biomea Fusion Shares Surge Over 6 as BMEA Tests Key Resistance ATI Inc ATI Edges Higher Testing Key Resistance Near 178 ATN International Holds Steady Modest Gains Amidst Key Support and Resistance Levels SpaceX Potential IPO A Look at Historys Biggest Stock Market Debuts EOG Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline First Business Financial Services FBIZ Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Enthusiasm NVCT Q1 2026 Earnings BetterthanExpected Loss Narrower as Company Advances Pipeline ICE Q1 2026 Earnings EPS Beat Amid Mixed Market Signals Shares Edge Lower Acumen Pharmaceuticals Q1 2026 Earnings Narrowed Loss Surprises as Alzheimers Pipeline Advances